Cell Source, Inc. engaged CBIZ CPAs P.C. as its auditor.
“with the approval of the Audit Committee of the Company’s Board of Directors, CBIZ CPAs was engaged as the Company’s independent registered public accounting firm”
Cell Source, Inc. — fact timeline
Source-grounded facts extracted from Cell Source, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Marcum LLP resigned as auditor of Cell Source, Inc..
“on June 26, 2025, Marcum resigned as the independent registered public accounting firm of Cell Source, Inc. (the “Company”)”
David Zolty resigned as director at Cell Source, Inc..
“On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).”
Ben Friedman resigned as director at Cell Source, Inc..
“On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).”
Itamar Shimrat resigned as Director at Cell Source, Inc..
“On May 6, 2022 Itamar Shimrat resigned his position as a director of Cell Source, Inc.”
George Verstraete was appointed as member of the Board at Cell Source, Inc..
“On March 10, 2022, the Board of Directors of the Company appointed George Verstraete as a member of the Board.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.